S0132: H1N1
Security context for executives and security teams
H1N1 matters because ATT&CK describes it as Windows malware delivered through VBA macros that evolved from a loader into information-stealing capability. For leaders, the practical issue is not just one malware name; it is whether the organization can see and contain a Windows intrusion path that may involve macro-enabled content, obfuscated or packed payloads, command-shell execution, credential theft from browsers, lateral spread through shared content or removable media, and concealed command-and-control traffic.
Executive priority
Treat H1N1 as a validation case for endpoint, email/document handling, credential protection, and incident response readiness on Windows. Priority questions: are macro-delivered payloads controlled and logged; can the SOC correlate command shell, file transfer, browser credential access, UAC bypass, firewall modification, and encoded/encrypted outbound traffic; and can IR teams preserve evidence quickly if security tooling, recovery features, or host firewall settings are modified. This supports budget and audit discussions around endpoint visibility, least privilege, removable media governance, backup/recovery assurance, and control evidence for malware prevention and response.
Technical view
MITRE does not provide official detection text for H1N1, so defenders should build coverage from the supplied behavior relationships. Validate Windows telemetry for VBA macro-originated process chains, packed or obfuscated files, cmd.exe execution, ingress tool transfer, browser credential store access, UAC bypass behavior, tainted shared locations, removable media replication, encoded or symmetrically encrypted C2-like communications, Windows host firewall changes, and potential impairment of security or recovery mechanisms. Because several related techniques list non-Windows platforms while the malware object itself is Windows, prioritize Windows-relevant evidence and document where ATT&CK relationship context requires local confirmation.
Likely telemetry
- Email gateway and endpoint evidence for macro-enabled Office documents and child-process execution from document applications
- Windows process creation telemetry, especially command shell execution and suspicious parent-child process chains
- Endpoint file telemetry for packed, encoded, encrypted, newly dropped, or renamed executables
- Network telemetry for external file transfer and encoded or encrypted command-and-control-like traffic patterns
- Browser credential store access, file reads, or process access events where available
Detection direction
- Do not rely on a malware signature alone; tune detections around behavior clusters such as macro-to-shell execution, dropped packed payloads, outbound transfer, and credential-store access.
- Correlate endpoint and network signals because data encoding and symmetric cryptography can reduce content-based network visibility.
- Baseline legitimate administrative use of cmd.exe, firewall changes, removable media, and shared-drive writes to reduce false positives while preserving high-risk combinations.
- Validate visibility on shared storage and removable media, which are common blind spots for lateral movement and initial access scenarios.
- Review whether EDR, logging, and recovery-control tampering alerts are collected centrally before a host becomes unavailable or evidence is altered.
Mitigation priorities
- Reduce macro-delivered malware risk through controlled macro policy, document-handling safeguards, and user-facing reporting paths for suspicious files.
- Harden Windows endpoints with least privilege, controlled elevation, and monitoring of UAC bypass-related behavior.
- Protect credentials by limiting browser password storage where appropriate, enforcing strong identity controls, and monitoring access to browser credential stores.
- Restrict and monitor removable media and shared content locations, especially where they bridge operational, sensitive, or less-managed systems.
- Ensure endpoint security, logging agents, host firewall policy, and recovery controls are centrally managed and monitored for unauthorized change.
Additional notes and limits
The object is a malware entry, not a technique, and the supplied ATT&CK record has no tactics and no official detection section. The strongest source-supported points are Windows platform scope, VBA macro distribution, evolution from loader to information stealing, and the listed technique relationships. Relationship-driven items such as recovery inhibition or tool impairment should be treated as coverage validation prompts rather than assumptions about every H1N1 incident.
This take uses only the provided ATT&CK fields, external references, and relationships. It does not establish current activity, attribution, prevalence, affected customers, or guaranteed detections. Local telemetry, sample analysis, control configuration, and incident evidence are required to determine actual exposure and coverage.
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
H1N1
How security teams should use this page
Treat this object as behavior context, not an attribution claim. Validate the related groups, software, data sources, and mitigations against official ATT&CK relationships and your own telemetry before making control-coverage decisions.
Techniques used
This mirrors the MITRE pattern of making group, software, campaign, and technique relationships scannable. Relationship notes come from mirrored ATT&CK relationship text when available.
| Domain | ID | Name | Relationship / procedure |
|---|---|---|---|
| Enterprise | T1555.003 | Credentials from Web BrowsersSub-technique | |
| Enterprise | T1080 | Taint Shared Content | |
| Enterprise | T1490 | Inhibit System Recovery | |
| Enterprise | T1027 | Obfuscated Files or Information | |
| Enterprise | T1059.003 | Windows Command ShellSub-technique | |
| Enterprise | T1091 | Replication Through Removable Media | |
| Enterprise | T1686.003 | Windows Host FirewallSub-technique | |
| Enterprise | T1548.002 | Bypass User Account ControlSub-technique | |
| Enterprise | T1027.002 | Software PackingSub-technique | |
| Enterprise | T1105 | Ingress Tool Transfer | |
| Enterprise | T1132 | Data Encoding | |
| Enterprise | T1573.001 | Symmetric CryptographySub-technique | |
| Enterprise | T1685 | Disable or Modify Tools |
All related ATT&CK context
Object version and sync metadata
The fields below describe the current mirrored snapshot. When Glexia retains multiple ATT&CK source imports, you can open the table to compare the same object across releases (hashes and MITRE timestamps). For MITRE’s own release notes and roadmap, see ATT&CK resources — Updates.
Imported snapshots across ATT&CK releases(1)
| Release | Bundle imported | Object version | Modified | Status | Raw hash |
|---|---|---|---|---|---|
| 19.1 | 1.2 | Current bundle | ab052b809b82… |
Mirrored ATT&CK source object
The raw object is retained through the mirrored ATT&CK source bundle and object hash. The raw endpoint returns the exact object from the mirrored bundle when available.
External references and citations
MITRE external references are preserved separately from Glexia analysis so citations remain traceable to their original source records.
- [1]Cisco H1N1 Part 1
Reynolds, J.. (2016, September 13). H1N1: Technical analysis reveals new capabilities. Retrieved September 26, 2016.
- [2]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [3]Cisco H1N1 Part 1
Reynolds, J.. (2016, September 13). H1N1: Technical analysis reveals new capabilities. Retrieved September 26, 2016.
- [4]Cisco H1N1 Part 1
Reynolds, J.. (2016, September 13). H1N1: Technical analysis reveals new capabilities. Retrieved September 26, 2016.
- [5]mitre-attackS0132Open source URL
- [6]mitre-attackS0132Open source URL
- [7]mitre-attackS0132Open source URL
- [8]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [9]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [10]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [11]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [12]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [13]Cisco H1N1 Part 1
Reynolds, J.. (2016, September 13). H1N1: Technical analysis reveals new capabilities. Retrieved September 26, 2016.
- [14]Cisco H1N1 Part 1
Reynolds, J.. (2016, September 13). H1N1: Technical analysis reveals new capabilities. Retrieved September 26, 2016.
- [15]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [16]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [17]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [18]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [19]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [20]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [21]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [22]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [23]Cisco H1N1 Part 1
Reynolds, J.. (2016, September 13). H1N1: Technical analysis reveals new capabilities. Retrieved September 26, 2016.
- [24]Cisco H1N1 Part 1
Reynolds, J.. (2016, September 13). H1N1: Technical analysis reveals new capabilities. Retrieved September 26, 2016.
- [25]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [26]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [27]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [28]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [29]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [30]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [31]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL - [32]Cisco H1N1 Part 2
Reynolds, J.. (2016, September 14). H1N1: Technical analysis reveals new capabilities – part 2. Retrieved November 17, 2024.
Open source URL
Source: MITRE ATT&CK®. © 2026 The MITRE Corporation. This work is reproduced and distributed with the permission of The MITRE Corporation. MITRE ATT&CK and ATT&CK are registered trademarks of The MITRE Corporation. Glexia is not affiliated with or endorsed by MITRE.
